Cilostazol 70436-0156-06
- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 1, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA077208
Need to source Cilostazol? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cilostazol | 50 mg/1 |
Drug Class
Phosphodiesterase 3 Inhibitor [EPC]Phosphodiesterase 3 Inhibitor [EPC]Phosphodiesterase 3 Inhibitors [MoA]
Selected Package
70436-0156-06Selected60 TABLET in 1 BOTTLE (70436-156-06)